Balazs Fejes - Aug 9, 2022 Form 4 Insider Report for EPAM Systems, Inc. (EPAM)

Signature
/s/ Kate Pytlewski as Attorney-in-Fact
Stock symbol
EPAM
Transactions as of
Aug 9, 2022
Transactions value $
-$16,332,271
Form type
4
Date filed
8/11/2022, 04:33 PM
Previous filing
May 3, 2022
Next filing
Jan 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EPAM EPAM Common Stock Options Exercise $1.3M +11.5K +88.9% $112.62 24.5K Aug 9, 2022 Direct
transaction EPAM EPAM Common Stock Options Exercise $1.31M +17.8K +72.71% $73.27 42.3K Aug 9, 2022 Direct
transaction EPAM EPAM Common Stock Options Exercise $1.3M +18.5K +43.62% $70.52 60.8K Aug 9, 2022 Direct
transaction EPAM EPAM Common Stock Sale -$20.2M -47.8K -78.66% $423.30 13K Aug 9, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EPAM Employee Stock Option (right to buy) Options Exercise $0 -11.5K -100% $0.00* 0 Aug 9, 2022 EPAM Common Stock 11.5K $112.62 Direct F3
transaction EPAM Employee Stock Option (right to buy) Options Exercise $0 -17.8K -100% $0.00* 0 Aug 9, 2022 EPAM Common Stock 17.8K $73.27 Direct F4
transaction EPAM Employee Stock Option (right to buy) Options Exercise $0 -18.5K -100% $0.00* 0 Aug 9, 2022 EPAM Common Stock 18.5K $70.52 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $416.12 to $427.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The option became exercisable as to 25% of the shares on each of March 23, 2019, 2020, 2021 and 2022.
F4 The option became exercisable as to 25% of the shares on each of March 24, 2018, 2019, 2020, and 2021.
F5 The option became exercisable as to 25% of the shares on each of March 25, 2017, 2018, 2019 and 2020.